top of page

Next Generation Biomanufacturing for the Bio-Revolution: An International Opportunity

Thursday, December 3, 2020 | 2:00 pm - 3:30 pm EST

2020WebinarSeries_biomanufacturing_650x3

Ontario Genomics is pleased to partner with Policy Horizons Canada and SynBio Canada as part of the Canada SynBio 2020 Canada’s Bio-Revolution Webinar Series. This panel discussion entitled "Next Generation Biomanufacturing for the Bio-Revolution: An International Opportunity" will examine engineering biology-driven manufacturing opportunities from an international perspective. Many leading G20 jurisdictions are already prioritizing engineering biology through significant investments into public-private partnerships and industry. This panel will specifically explore initiatives and strategies in the USA, UK, and Canada.

​

This much-needed conversation will bring together diverse voices and perspectives from across the value chains of leading experts - researchers, industry, funders and advocates, to generate collaboration and amplify new ideas.

 

Discussion topics include:

  • The biomanufacturing opportunity and challenges across jurisdictions

  • The impact on and opportunities for traditional economic sectors and industries

  • The convergence of technologies that are enabling innovations, commercialization, job creation, and economic growth

  • Opportunities for international collaboration

  • Impact of the pandemic on local supply chains

  • Power of biomanufacturing and engineering biology to address climate change and a greener economy through low carbon emissions

​

AGENDA

OPENING REMARKS:

PANEL:

  • Moderated by Dr. Bettina Hamelin, President & CEO, Ontario Genomics and Chair, National Engineering Biology Steering Committee

  • Dr. Aaron Dulgar-Tulloch, Global Head of Research and Development, Director of Cell and Gene Therapy, Cytiva (formerly GE Life Sciences), Canada

  • Dr. Doug Friedman, CEO, BioMADE & EBRC, USA

  • Pari Johnston, Vice President, Genome Canada, Canada

  • Dr. Kirk Malone, Director of Commercialization, UK Future Biomanufacturing Research Hub (Future BRH), UK

  • Dr. Renee Wegrzyn, Vice President Business Development, Gingko Bioworks, USA

CSPC2020 - Canadian Science Policy Conference

Monday, November 16, 2020 | 2:30 pm - 4:00 pm
Concurrent Session Organized by Ontario Genomics

CSPC_Banner-760x380.jpg

637: A Canadian Engineering Biology Roadmap: Building our Biomanufacturing Future

The "bio-revolution" is here, promising to create US$2-$4 trillion in global value between 2030-2040. By converging genomics and molecular biosciences with engineering, automation, and AI, engineering biology emerges as a transformational, productive, and sustainable technology platform to revolutionize healthcare, agriculture, food security and biomanufacturing. Leading G20 jurisdictions are already making significant investment into engineering biology strategies and industries. Canada can and must compete in this global bio-revolution. Members of the Canadian Engineering Biology Steering Committee and broader community will discuss the urgency to support Canadian-made engineering biology solutions to remain globally competitive and promote economic growth and stability in a pandemic and post-pandemic world.

​

Speakers:

  • Bettina Hamelin President & CEO, Ontario Genomics

  • Lakshmi Krishnan VP, Life Sciences (Acting); Director General, Human Health Therapeutics, National Research Council

  • Peter Zandstra Director, School of Biomedical Engineering, Michael Smith Laboratories

  • Vardit Ravitsky Professor, University of Montreal

  • Vincent Martin Professor, Concordia University

  • Adam Westbrook Metabolic Engineering Lead, Genecis Bioindustries

Canada’s Bio-Revolution Webinar Series
New Frontiers in Food Production: Growing Stronger with Cellular Agriculture

Tuesday, October 27, 2020 | 12:00 pm - 1:00 pm EST

2020WebinarSeries_AG-FOOD_650x325-MCh.jp

In the second installment of our Canada SynBio Webinar Series entitled "Canada's Bio-Revolution," Ontario Genomics is partnering with the Arrell Food Institute and Canadian Agri-Food Policy Institute as part of their Growing Stronger initiative. This webinar is also brought to you in partnership with the Global Institute for Food Security.

 

The panel will focus on the future of Canada's food system and how it can benefit from new technologies, including cellular agriculture (using cells to make food products, e.g. meat, dairy, eggs, alternative proteins, ingredients) and the role they can play in creating "made-in-Canada" solutions for a more resilient food supply chain in a post-COVID world.

​

This much-needed conversation will bring together diverse voices and perspectives from across the value chains of leading Canadian experts - researchers, industry, funders and advocates, to generate collaboration and amplify new ideas.

​

Topics include:

  • The current state of play for cellular agriculture,

  • The opportunities and potential barriers,

  • How genomics/engineering biology can help and how this can contribute to sustainability.

 

We are especially interested in how these new technologies can be synergistic with traditional approaches to feed people in Canada and abroad. The outputs from this discussion will input into the draft policy recommendations put forth by the Growing Stronger initiative and inform the food security pillar of Can-DESyNe, Canada's DNA Engineering Systems Network.

AGENDA

Opening Remarks: Dr. Bettina Hamelin, President & CEO, Ontario Genomics and Chair, National Engineering Biology Steering Committee

Panel: Moderated by Dr. Steven Webb, Executive Director and Chief Executive Officer, the Global Institute for Food Security, Member of National Engineering Biology Steering Committee

Closing Remarks: Dr. Bettina Hamelin, President & CEO, Ontario Genomics and Chair, National Engineering Biology Steering Committee

2020WebinarSeries_Banner-980x300.png

We are thrilled to partner with the Gairdner Foundation to bring you one of their Global Perspectives Panels as our first webinar of this series. "Editing our Economic Future: The Power of CRISPR” will showcase a conversation between Gairdner Foundation laureates and leading Canadian researchers on using the opportunities and applications of gene editing, specifically by using CRISPR/Cas9, to transform multiple sectors, from therapeutics to diagnostics, agriculture, and low carbon manufacturing, all of which will have a profound impact on our economy.

This discussion with centre on the development of these molecular tools and their applications, and potential challenges to adoption. In addition, Canadian researchers will speak about how they are applying gene editing to address problems like cancer treatment and fungal resistance for crops.

Editing our Economic Future:

The Power of CRISPR

WHAT

Monday, September 28, 2020

12:00 to 1:00 PM

WHEN

Zoom Webinar

(Register now)

WHERE

AGENDA

Opening Remarks: Dr. Bettina Hamelin, President & CEO, Ontario Genomics and Chair, National Engineering Biology Steering Committee

Panel: Moderated by Dr. Janet Rossant, President and Scientific Director, Gairdner Foundation

Closing Remarks: Dr. Bettina Hamelin, President & CEO, Ontario Genomics and Chair, National Engineering Biology Steering Committee

bottom of page